Abstract:Immune-based therapeutic approaches for IBD, including anti-TNF therapy, have shown significant success during the last decade. Nevertheless, many patients are not responsive to these therapies and suffer from severe side effects. Therefore, an increased understanding of the fundamental immune mechanisms controlling gut inflammation is critical for the rational design and development of more effective therapies of IBD. Innate lymphoid cells (ILCs) have recently emerged as key players in regulating the balance between protective immunity and immunopathology at mucosal surfaces. However, the cellular and molecular pathways that control crosstalk between ILCs and intestinal epithelial cells during inflammation remain poorly understood. Our recent study revealed that Lymphotoxin (LT), a member of TNF superfamily of cytokines, produced by RORgt+ ILCs in the gut is critical for protection against the mucosal bacterial pathogen Citrobacter rodentium. In the present study, we aimed to determine how LT signaling controls ILCs to regulate the intestinal inflammation. An acute mouse model of IBD induced by dextran sodium sulfate (DSS) was used. WT and LT-beta receptor (LTbR)-deficient mice were treated with 3.5% DSS in drinking water for 5 days followed by normal water thereafter. Our data show that LTbR signaling is essential for protection and recovery from DSS-induced colitis. LTbR deficient mice failed to upregulate IL-22 in the colon and succumbed rapidly after DSS administration. By using RORgt-GFP reporter mice and cell sorting approach we found the impaired IL-22 production by distinct populations of ILCs in the colon after DSS-induced inflammation. Recent studies indicated a protective role of IL-22 in IBD by enhancing barrier integrity and epithelial innate immunity. We found that reduced IL-22 expression in LTbR-deficient mice was associated with defected mucin genes expression and impaired proliferation of intestinal epithelial cells after DSS-induced injury. Bone marrow transfer experiments revealed that LTbR expression on both bone marrow-derived and radioresistant stromal cells is required for the control of intestinal inflammation. To define which LTbR-expressing cells are essential for protection, we have generated mice with a specific inactivation of LTbR in intestinal epithelial cells, and bone marrow-derived cell populations. These mouse models will help us to further investigate the critical pathways to control intestinal inflammation. Our data indicate that LTbR signaling prevents intestinal inflammation by controlling the IL-22 protection pathway.

Early-life programming of mesenteric lymph node stromal cell identity by the lymphotoxin pathway regulates adult mucosal immunity

Perinatal Programming of Mucosal Stromal Cell Identity by the Lymphotoxin Pathway Regulates Mucosal Immune Responses in the Adult

Lymphoid Microenvironment In The Gut For Immunoglobulin A And Inflammation

The Interaction Between Lymphoid Tissue Inducer-Like Cells and T Cells in the Mesenteric Lymph Node Restrains Intestinal Humoral Immunity.

Langerhans cells regulate immunity in adulthood by regulating postnatal dermal lymphatic development

Embryonic macrophages function during early life to determine invariant natural killer T cell levels at barrier surfaces

Signaling via LTβR on the lamina propria stromal cells of the gut is required for IgA production

Transcriptional Regulation of Early T-Lymphocyte Development in Thymus

Lymphotoxin-Dependent Control of Intestinal Inflammation

Epithelial Lymphotoxin Beta Receptor Regulates Embryonic Medullary Thymic Epithelial Cell Development for Central Tolerance (BA14P.212)

Postnatal expansion of mesenteric lymph node stromal cells towards reticular and CD34+ stromal cell subsets

MLL1 directs gut-associated antibody responses to helminth and bacterial infections

Lymphotoxin-dependent Control of Innate Immune Responses in the Gut

Lymph Node Stromal Cells From Different Draining Areas Distinctly Regulate the Development of Chronic Intestinal Inflammation

Peripheral Lymphoid Volume Expansion and Maintenance Are Controlled by Gut Microbiota via RALDH+ Dendritic Cells

Recipient tissue microenvironment determines developmental path of intestinal innate lymphoid progenitors

Early-life vitamin A treatment rescues neonatal infection-induced durably impaired tolerogenic properties of celiac lymph nodes

Erythroid differentiation regulator-1 induced by microbiota in early life drives intestinal stem cell proliferation and regeneration

The Development of Steady-State Activation Hubs between Adult LTi ILC3s and Primed Macrophages in Small Intestine

TSLP/dendritic cell axis promotes CD4+ T cell tolerance to the gut microbiome